Company / Shareholders' Equity
BioRestorative Therapies, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$356.7K
FY2025
5-year range
$356.7K / $21.6M
FY2021-FY2025
Trend
-96.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $10M to $356,744 over the past 2 years.
Based on SEC 10-K filings.
$356,744 in FY2025 with a 3-year CAGR of -67.4%.
Declined from $10M to $356,744 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -67.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -67.4%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 96.4% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $356.7K | -96.4% |
| FY2024 | $10.0M | +0.0% |
| FY2023 | $10.0M | -2.8% |
| FY2022 | $10.3M | -52.4% |
| FY2021 | $21.6M | +269.0% |
| FY2020 | -$12.8M | -47.9% |
| FY2019 | -$8.6M | -26.4% |
| FY2018 | -$6.8M | -36.7% |
| FY2017 | -$5.0M | -27.9% |
| FY2016 | -$3.9M | +43.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026